{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:21:19Z","timestamp":1789050079122,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.vhri.2024.01.003","type":"journal-article","created":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T04:52:55Z","timestamp":1714193575000},"page":"100981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Tiered Pricing and Alternative Mechanisms for Equitative Access to Vaccines in Latin America: A Narrative Review of the Literature"],"prefix":"10.1016","volume":"42","author":[{"given":"Adriana","family":"Arango-Luque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Yucum\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo E.","family":"Casta\u00f1eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Espin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Becerra-Posada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vhri.2024.01.003_bib1","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1186\/s12913-017-2626-0","article-title":"Determinants of effective vaccine coverage in low and middle-income countries: a systematic review and interpretive synthesis","volume":"17","author":"Phillips","year":"2017","journal-title":"BMC Health Serv Res"},{"issue":"9936","key":"10.1016\/j.vhri.2024.01.003_bib2","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/S0140-6736(13)62424-1","article-title":"Improving access to vaccines through tiered pricing","volume":"383","author":"Berkley","year":"2014","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.vhri.2024.01.003_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/vaccines10101675","article-title":"Influenza Vaccination Assessment according to a Value-Based Health Care Approach","volume":"10","author":"Calabro","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.vhri.2024.01.003_bib5","first-page":"1","article-title":"A\u00a0win-win solution?: a critical analysis of tiered pricing to improve access to medicines in developing countries","volume":"7","author":"Moon","year":"2011","journal-title":"Global Health"},{"issue":"suppl 1","key":"10.1016\/j.vhri.2024.01.003_bib6","doi-asserted-by":"crossref","first-page":"A93","DOI":"10.1016\/j.vaccine.2014.12.076","article-title":"What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries?","volume":"33","author":"Brenzel","year":"2015","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vhri.2024.01.003_bib8","first-page":"1","article-title":"COVID-19 vaccines pricing policy options for low income and middle income countries","volume":"6","author":"Guzman","year":"2021","journal-title":"BMJ Glob Heal"},{"issue":"10278","key":"10.1016\/j.vhri.2024.01.003_bib10","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(21)00306-8","article-title":"Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation and deployment","volume":"397","author":"Wouters","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vhri.2024.01.003_bib16","first-page":"1","article-title":"Desarrollo, distribuci\u00f3n y suministro de vacunas","volume":"XLII","year":"2020","journal-title":"Bol Inmunizaci\u00f3n"},{"key":"10.1016\/j.vhri.2024.01.003_bib17","series-title":"An evaluation of price determinants and the economics of supplying vaccines: a tradeoff between the wealth of firms and the health of nations","author":"Ekman","year":"2020"},{"issue":"111","key":"10.1016\/j.vhri.2024.01.003_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/0103-1104201611101","article-title":"La articulaci\u00f3n p\u00fablico-privada en la producci\u00f3n de vacunas en M\u00e9xico","volume":"40","author":"Tamez","year":"2016","journal-title":"Sa\u00fade Debate"},{"key":"10.1016\/j.vhri.2024.01.003_bib19","first-page":"14","article-title":"Plan de acci\u00f3n mundial sobre vacunas plan de acci\u00f3n mundial sobre vacunas","year":"2013","journal-title":"Panor Actual Inmunizacion"},{"issue":"253","key":"10.1016\/j.vhri.2024.01.003_bib20","doi-asserted-by":"crossref","first-page":"253ps11","DOI":"10.1126\/scitranslmed.3009848","article-title":"Contemporary vaccine challenges: improving global health one shot at a time","volume":"6","author":"Orenstein","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vhri.2024.01.003_bib21","doi-asserted-by":"crossref","first-page":"S414","DOI":"10.2105\/AJPH.2014.302236r","article-title":"Improving global access to new vaccines: intellectual property, technology transfer, and regulatory pathways","volume":"108","author":"Crager","year":"2018","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vhri.2024.01.003_bib22","author":"Keller"},{"issue":"1","key":"10.1016\/j.vhri.2024.01.003_bib24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1377\/hlthaff.2020.01548","article-title":"Consideration of value based pricing for tratments and vaccines is important, even in the COVID-19 Pandemic","volume":"40","author":"Neumann","year":"2021","journal-title":"Health Aff"},{"key":"10.1016\/j.vhri.2024.01.003_bib25","volume":"19","author":"Emond","year":"2020"},{"issue":"2-3","key":"10.1016\/j.vhri.2024.01.003_bib26","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1177\/0098858816658280","article-title":"The economic theory of patent protection and pandemic influenza vaccines: do patents really incentivize innovation in the field?","volume":"42","author":"Eccleston-Turner","year":"2016","journal-title":"Am J Law Med"},{"issue":"1","key":"10.1016\/j.vhri.2024.01.003_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12914-014-0037-4","article-title":"Could international compulsory licensing reconcile tiered pricing of pharmaceuticals with the right to health?","volume":"14","author":"Ooms","year":"2014","journal-title":"BMC Int Health Hum Rights"},{"key":"10.1016\/j.vhri.2024.01.003_bib28","author":"Herrera"},{"key":"10.1016\/j.vhri.2024.01.003_bib29","first-page":"9","year":"2009","journal-title":"Gavi the Vaccine Alliance. Key Concepts : Tiered Pricing"},{"key":"10.1016\/j.vhri.2024.01.003_bib30","author":"Yadav"},{"key":"10.1016\/j.vhri.2024.01.003_bib32","author":"Lawlor"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109924000116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109924000116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T12:01:11Z","timestamp":1751371271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109924000116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":22,"alternative-id":["S2212109924000116"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2024.01.003","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tiered Pricing and Alternative Mechanisms for Equitative Access to Vaccines in Latin America: A Narrative Review of the Literature","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2024.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society for Health Economics and Outcomes Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100981"}}